MILLIPLEX^® Human Cytokine/Chemokine/Growth Factor Panel B

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

MILLIPLEX^® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze 48 analytes in human serum, plasma, and cell culture supernatants.Analytes included: 6Ckine, sCD137, sFAS, sFASL, APRIL, BAFF, BCA-1, CCL28, CTACK, CXCL16, ENA-78, Eotaxin-2, Eotaxin-3, GCP-2, Granzyme A, Granzyme B, HMGB1, I-309, IFNβ, IFNψ, IL-11, IL-16, IL-20, IL-21, IL-23, IL-24, IL-28A, IL-29, IL-31, IL-33, IL-34, IL-35, I-TAC, LIF, Lymphotactin, MCP-2, MCP-4, MIP-1δ, MIP-3α, MIP-3β, MPIF-1, Perforin, SCF, SDF-1, TARC, TPO, TRAIL, TSLPAssay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Premixed Beads: Save time and reduce preparation errors with ready-to-use reagents.Cytotoxicity Markers: Quantify Granzyme A/B and Perforin to assess T/NK cell activity in cancer or infection.Comprehensive Immune Profiling: Covers cytokines (IL-31), chemokines (TARC), and growth factors (SCF) allowing you to uncover immune network dynamics holistically.Emerging Biomarker Inclusion: Quantify IL-35 (immune suppression) and TSLP (allergic inflammation), key targets in next-gen immunotherapy and allergy research. Pioneer studies on regulatory pathways and therapeutic modulation.Automation-Ready Format: Compatible with liquid handlers and robotic platforms, allowing you to scale workflows for high-volume studies without compromising precision.

Cytokines, chemokines, and growth factors are key mediatorsof immune system functions capable of signaling through autocrine, paracrine,and endocrine mechanisms. Their pleiotropic immunomodulatory propertiesallow these biomolecules to react to diverse stimuli and regulate the immuneresponse, either promoting or inhibiting inflammation.